Protagonist Therapeutics to Participate in Four Investment Bank Conferences
Bitget2026/10/27 11:01- Protagonist Therapeutics senior management will attend four investment bank conferences in November 2026.
- The 8th Annual Wolfe Research Healthcare Conference takes place November 10 in New York; fireside chat scheduled for 1:20–1:50 p.m. EST.
- Truist Securities 2026 Biopharma Symposium participation includes one-on-one meetings November 12 in New York.
- UBS Global Biopharma Conference attendance includes a fireside chat November 16 in London, scheduled for 12:40–1:10 p.m. GMT.
- Jefferies Global Healthcare Conference participation includes a fireside chat November 17 in London, scheduled for 8:30–8:55 a.m. GMT.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Vodafone (VOD.US) Swings to Loss in First Half, German Operations Major Drag
Vodafone (VOD.US) released its financial results for the first half of fiscal year 2027.
AI gamble backfires! Data center project writedowns and weak tech stock positions drag down SoftBank (SFTBY.US) to a Q2 loss of $7.1 billion
SoftBank recorded its first net loss in nearly two years due to a $3.7 billion impairment loss arising from a U.S. data center project, coupled with mounting market concerns over the sustainability of artificial intelligence (AI) growth impacting the investment giant’s key holdings.
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish
CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.
JPMorgan raises target prices for Target and Walmart
Crypto prices
More
